Structure-based discovery of a family of synthetic cyclophilin inhibitors showing a cyclosporin-A phenotype in Caenorhabditis elegans.

Cyclophilins, which are found in all cellular compartments and with diverse biological roles, are now drug targets for a number of diseases including HIV infection, malaria and ischaemia. We used the database-mining program LIDAEUS and in silico screening to discover the dimedone family of inhibitors which show a conserved 'ball and socket' binding mode with a dimethyl group in the hydrophobic binding pocket of human cyclophilin A (CypA) mimicking a key interaction of the natural inhibitor cyclosporin A (CsA). The most potent derivative binds CypA with a K(d) of 11.2+/-9.2 microM and an IC50 for activity against Caenorhabditis elegans (C. elegans) of 190 microM compared to 28 microM for CsA. These dimedone analogues provide a new scaffold for the synthesis of families of peptidomimetic molecules with potential activity against HIV, malaria, and helminth parasite infections.

[1]  D. Walters,et al.  Structure based design: novel spirocyclic ethers as nonpeptidal P2-ligands for HIV protease inhibitors. , 1998, Bioorganic & medicinal chemistry letters.

[2]  G. Fischer,et al.  Insights into the catalytic mechanism of peptidyl prolyl cis/trans isomerases. , 2004, Frontiers in bioscience : a journal and virtual library.

[3]  A. Matouschek,et al.  Cyclophilin catalyzes protein folding in yeast mitochondria. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Luban,et al.  Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses , 1996, Journal of virology.

[5]  Jean-François Guichou,et al.  Structure-based design, synthesis, and biological evaluation of novel inhibitors of human cyclophilin A. , 2006, Journal of medicinal chemistry.

[6]  Determination of kinetic constants for peptidyl prolyl cis-trans isomerases by an improved spectrophotometric assay. , 1991 .

[7]  M. Walkinshaw,et al.  Thermodynamics of the cyclophilin-A/cyclosporin-A interaction: a direct comparison of parameters determined by surface plasmon resonance using Biacore T100 and isothermal titration calorimetry. , 2006, Analytical biochemistry.

[8]  Stuart L. Schreiber,et al.  Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes , 1991, Cell.

[9]  K. Shimotohno,et al.  Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase. , 2005, Molecular cell.

[10]  M. Hengartner,et al.  Cloning and biochemical characterization of the cyclophilin homologues from the free-living nematode Caenorhabditis elegans. , 1996, The Biochemical journal.

[11]  B. Cullen.  HIV-1 infection: fooling the gatekeeper , 2003, Nature Medicine.

[12]  M. Crompton,et al.  Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. , 1998, European journal of biochemistry.

[13]  J. Luban,et al.  Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription , 1996, Journal of virology.

[14]  J. Luban,et al.  Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A , 1996, Journal of virology.

[15]  A. Winter,et al.  Enzymes involved in the biogenesis of the nematode cuticle. , 2003, Advances in parasitology.

[16]  M. Tremblay,et al.  Plunder and Stowaways: Incorporation of Cellular Proteins by Enveloped Viruses , 2005, Journal of Virology.

[17]  K. Shimotohno,et al.  [Current approaches for developing new anti-HCV agents and analyses of HCV replication using anti-HCV agents]. , 2005, Uirusu.

[18]  C. Frasch,et al.  Effect of O Acetylation of Neisseria meningitidis Serogroup A Capsular Polysaccharide on Development of Functional Immune Responses , 2002, Infection and Immunity.

[19]  Su-Ying Wu,et al.  Discovery of a novel family of CDK inhibitors with the program LIDAEUS: structural basis for ligand-induced disordering of the activation loop. , 2003, Structure.

[20]  J. Lemasters,et al.  Cyclophilin D as a drug target. , 2003, Current medicinal chemistry.

[21]  J. Luban,et al.  Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization , 1996, Journal of virology.

[22]  A. Bell,et al.  Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin. , 1994, Biochemical pharmacology.

[23]  Nicholas J Turner,et al.  A surface plasmon resonance-based assay for small molecule inhibitors of human cyclophilin A , 2005, Analytical Biochemistry.

[24]  J. Luban,et al.  Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. , 1996, Virology.

[25]  C. Carlow,et al.  Parasite cyclophilins and antiparasite activity of cyclosporin A. , 1995, Parasitology today.

[26]  D. Speicher,et al.  Cyclophilin: a specific cytosolic binding protein for cyclosporin A. , 1984, Science.

[27]  Jeffrey Robbins,et al.  Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death , 2005, Nature.

[28]  P. Bieniasz,et al.  Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors , 2003, Nature Medicine.

[29]  M. Walkinshaw,et al.  Experimental determination of van der waals energies in a biological system. , 2007, Angewandte Chemie.

[30]  C. S. Gavigan,et al.  Cyclosporin-binding proteins of Plasmodium falciparum. , 2003, International journal for parasitology.

[31]  P. Truffa-bachi,et al.  The impact of immunosuppressive drugs on the analysis of T cell activation. , 2000, Current medicinal chemistry.

[32]  B. Cullen.  HIV-1 Vif: counteracting innate antiretroviral defenses. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[33]  Andrzej Galat,et al.  Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity--targets--functions. , 2003, Current topics in medicinal chemistry.

[34]  P. Taylor,et al.  Enzymatic and structural characterization of non-peptide ligand-cyclophilin complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.